# Methotrexate for Severe Vulvar Lichen Sclerosus

> **NCT07352917** · PHASE2 · RECRUITING · sponsor: **Clinica Dermatologica Arbache ltda** · enrollment: 12 (estimated)

## Conditions studied

- Vulvar Lichen Sclerosus

## Interventions

- **DRUG:** Methotrexate (MTX)

## Key facts

- **NCT ID:** NCT07352917
- **Lead sponsor:** Clinica Dermatologica Arbache ltda
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-21
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07352917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07352917, "Methotrexate for Severe Vulvar Lichen Sclerosus". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07352917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*